Showing results (21-30 of 120) with videos related to
Sort By:
Pageof 12
Israel Journal of Medical Sciences|April 1, 1985
Amodiaquine-induced agranulocytosis: drug inhibition of myeloid colonies in the presence of patient's serumD Douer, E Schwartz, N Shaked, et al.Blood|April 1, 1985
Production of burst-promoting activity by monoclonal antibody defined malignant T lymphocytes from patients with lymphocytic leukemia and lymphomaP Froom, B Ramot, M Biniaminov, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1987
Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicityY Kaufmann, M Levanon, J Davidsohn, et al.Clinical and Experimental Immunology|January 1, 1983
Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunityJ Passwell, M Levanon, J Davidsohn, et al.Blood|September 1, 1975
Complement-sensitive red cells in aplastic anemiaI Ben-Bassat, F Brok-Simoni, B RamotActa Haematologica|January 1, 1984
Human bone marrow fibroblast proliferation and GM-CFC colony formation in patients with acute leukemiaD Lieberman, D Meytes, N Shacked, et al.Clinical and Experimental Immunology|July 1, 1977
Ferritin on the surface of lymphocytes in Hodgkin's disease patients. A possible blocking substance removed by levamisoleC Moroz, N Lahat, M Biniaminov, et al.Clinical and Experimental Immunology|January 1, 1978
The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patientsR Michalevicz, A Many, B Ramot, et al.The New England Journal of Medicine|April 8, 1976
Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's diseaseB Ramot, M Biniaminov, C Shoham, et al.Clinical and Experimental Immunology|January 1, 1975
Galactose oxidase-induced blastogenesis of human lymphocytes and the effect of macrophages on the reactionM Biniaminov, B Ramot, E Rosenthal, et al.Pageof 12